Clinical Trial

Real-world Immunogenicity of Anti-IL5/5a Antibody

Name: Real-world Immunogenicity of Anti-IL5/5a Antibody — clinical trial record (NCT07567690)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the immunogenicity of the drug by measuring anti-drug antibody (ADA) formation and titers. The presence of ADAs will be assesses to determine their potential impact on the drug's efficacy and safety.

Trial Details

NCT Number	NCT07567690
Lead Sponsor	Samsung Medical Center
Conditions	Asthma, Immunogenicity, Biologics
Enrollment	100 participants
Start Date	2025-08-19
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-05